ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Understanding and preventing generation of explosive hydrazoic acid (HN3) is key to safe and successful scale-up of azide chemistry, report researchers from Bristol-Myers Squibb (Org. Process Res. Dev., DOI: 10.1021/op3002646). Azide compounds are commonly used to synthesize nitrogen-containing species. But they present several safety challenges, one of which is possible accumulation of HN3 , which is explosive. As part of scaling up the synthesis of a pharmaceutical candidate, a team led by Francisco González-Bobes and Nathaniel Kopp was working on an enantioselective, palladium-catalyzed desymmetrization of a meso-bis-ester using trimethylsilylazide (TMSN3) as a nucleophile. Rather than using engineering controls to manage HN3, the team looked for ways to minimize its formation through process design. One approach involved tightly controlling unreacted azide by making TMSN3 the limiting reagent, but that sacrificed some of the meso-bis-ester starting material. The team then developed a method in which, after desymmetrization, the reaction solution is treated with sodium hydroxide to convert any residual TMSN3 to aqueous sodium azide. An extraction step removes the aqueous component. The team demonstrates that the end result is a safer process with better yield and less waste.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on Twitter